Future Science Group

In this podcast, Juandem Agendia and Sarah Alexander (NCTC, UK) discuss bacteriophages, the function of the NCTC and the importance of depositing bacteriophages in the NCTC collection to improve accessibility and reproducibility in science.

OCTalks: Comprehensive Genomic Profiling by Future Science Group

OCTalks: the ethics of COVID-19 and cancer by Future Science Group

OCTalks: targeting FGFR2 in advanced cholangiocarcinoma by Future Science Group

The importance of data management: an interview with Xiaonan Tang by Future Science Group

Brendan Griffin (University College Cork, Ireland)discusses his work in early drug development in this interview with Bioanalysis Zone. Brendan talks about the most common challenges faced as well as key trends in the field of developability. For more content, visit www.bioanalysis-zone.com

In this Technique Blast – a new series that will provide short informative discussions about a specific technique – Digital Editor Tristan Free speaks to Joseph Pesek about high-performance liquid-chromatography and chromatographic separation technologies.

In the face of the COVID-19 pandemic, innovators are finding novel ways to apply 3D-printed solutions to assist the international response to coronavirus. From meeting PPE demands, to designing novel approaches to unique challenges, the additive community has not been short of opportunity for collaboration and corroboration with multidisciplinary teams exploring options for aiding crises from local to international capacities. In this podcast, in collaboration with Women in 3D Printing, we invited a panel of experts to take a look at how the additive community has responded to coronavirus, where the limitations lie in integrating 3D-printed devices into a health system under pressure as well as what can be done by the wider 3D printing community to help overcome critical challenges posed by COVID-19. Meet the experts > Maxine Chan Director of Med Supply Drive UK, NHS Obstetrician and Gynaecologist, PhD Researcher in Bioengineering and Regenerative Medicine, Imperial College London (UK) Maxine Chan is an

Integrating patient-relevant outcomes into clinical practice: an interview with Donna Messner by Future Science Group

NCTalks with Gavin Giovannoni: advancements in the treatment landscape for multiple sclerosis by Future Science Group

Comparing real-world and randomized controlled trial data: an interview with Michael Moran by Future Science Group

BioTechniques Digital Editor Tristan Free, speaks to Application Scientist Theresa Thompson and Strategy Director Jay Pasquantonio (both Phoseon Technology) about their UV LEDs. We cover the best wavelengths for disrupting nucleotides and proteins, the challenges associated with some of these wavelengths, and the promising potential of UV LEDs to disinfect inorganic surfaces of SARS-CoV-2. Theresa and Jay also detail the safety procedures required while using this technology and deliver a clear warning against the irradiation of organic matter with UV LEDs.

Estimating the opportunity–cost-based cost–effectiveness threshold: a panel discussion by Future Science Group

In the first installment of this two-part episode with Donald Ingber, Founding Director of the Wyss Institute (MA, USA), we discuss his invention of organ-on-a-chip technology, how he is utilizing them in the fight against COVID-19 and the Wyss Institute's response to the pandemic. Donald touches on the performance of the much-discussed chloroquine in his lung-on-a-chip models. We also discuss the pros and cons of organ-on-a-chip technology verses organoids, exploring their use in combination, before Donald examines the possible replacement of animal models with organ-on-a-chip technology.

In this episode BioTechniques Digital Editor, Tristan Free speaks to Annie Evans, Director of R&D and David Foster, Vice President of Data and Informatics at Metabolon about the latest developments in microbiome studies, including big data analysis, LCMS, alpha diversity and at-home fecal sample collection.

In this episode BioTechniques Digital Editor, Tristan Free, speaks to Paul Brennan, President and CEO of NervGen, about the company's new technique, currently under development, for repairing nerve damage and it's potential for treating Alzheimer's. Paul also covers some of the gaps in Alzheimer's research and wades in on the Tau vs Amyloid Beta debate.

Talking at ASCB 2019 in Washington, Andrea Brand, Head of the Gurdon Institute's Wellcome labs, and BioTechniques Digital Editor Tristan Free, discuss Andrea's work in neural stem cells and brain cancers. Andrea's novel technique for analyzing proteins binding throughout the genome, TADA, which can be employed in live animals, is also explored alongside the integration of genetic and imaging techniques for successful studies.

Hello, and welcome to this episode of OC talks Podcast Series brought to you by Oncology Central. I am Jade Parker, Senior Editor of Oncology Central, a free online platform that unites all aspects of oncology to support a multidisciplinary approach to progression of the field. In this episode today, we will be speaking to Wout Brusselaers from Deep6 AI about how artificial intelligence (AI) is changing clinical trial feasibility and recruitment. Thank you for joining us today, Wout.

Digital Editor Tristan Free and Digital Intern Theo Kemp, speak to Stephen Taylor of The MRC Weatherall Institute of Molecular Medicine. Stephen discusses his work in developing novel systems to interpret biomedical data sets and CSyth; the visualization program for DNA folding.

The vitality of vital statistics: an interview with Alan Lopez by Future Science Group